BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 20307220)

  • 1. Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.
    Razeghinejad MR; Sawchyn AK; Katz LJ
    Expert Opin Pharmacother; 2010 Apr; 11(6):959-68. PubMed ID: 20307220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K; Snyder E; DuBiner H; Adamsons I
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide.
    Clineschmidt CM; Williams RD; Snyder E; Adamsons IA
    Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of two fixed combinations: timolol-dorzolamide-brimonidine versus timolol-dorzolamide. A prospective, randomized, double-masked, multi-center, 6-month clinical trial.
    Baiza-Durán LM; Alvarez-Delgado J; Contreras-Rubio AY; Medrano-Palafox J; De Luca-Brown A; Casab-Rueda H; Cortés-Gastélum MA; Garcidueñas-Mejía MJ; Gómez-Bastar P; Gil-Carrasco F; Hartleben-Matkin C; Jiménez-Román J; Moreno-Marín ML; Paczka-Zapata JA; Velasco-Gallegos G; Vergara-Sinta M
    Ann Ophthalmol (Skokie); 2009; 41(3-4):174-8. PubMed ID: 20214051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glaucoma: an ocular blood flow disorder?].
    Recker K
    Ophthalmologe; 2003 Feb; 100(2):2 p following 174. PubMed ID: 12650170
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma.
    Konstas AG; Kozobolis VP; Tersis I; Leech J; Stewart WC
    Eye (Lond); 2003 Jan; 17(1):41-6. PubMed ID: 12579169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brimonidine and timolol fixed-combination therapy versus monotherapy: a 3-month randomized trial in patients with glaucoma or ocular hypertension.
    Craven ER; Walters TR; Williams R; Chou C; Cheetham JK; Schiffman R;
    J Ocul Pharmacol Ther; 2005 Aug; 21(4):337-48. PubMed ID: 16117698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Azarga, a new and useful fixed combination in glaucoma treatment].
    Călugăru M; Călugăru D
    Oftalmologia; 2011; 55(3):38-46. PubMed ID: 22428291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with Cosopt, the fixed combination of timolol and dorzolamide, after switch from free combination of timolol and dorzolamide, in Swiss ophthalmologists' offices.
    Gugleta K; Orgül S; Flammer J
    Curr Med Res Opin; 2003; 19(4):330-5. PubMed ID: 12841926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signs and symptoms of ocular surface status in glaucoma patients switched from timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month efficacy and tolerability, multicenter, open-label prospective study.
    Rossi GC; Tinelli C; Pasinetti GM; Fusetti M; Pallavicini C; Stringa M; Vacchi S; Stringa F; Bianchi PE
    Expert Opin Pharmacother; 2011 Apr; 12(5):685-90. PubMed ID: 21385109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension.
    Heijl A; Strahlman E; Sverrisson T; Brinchman-Hansen O; Puustjärvi T; Tipping R
    Ophthalmology; 1997 Jan; 104(1):137-42. PubMed ID: 9022118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed-combination brimonidine/timolol as adjunctive therapy to a prostaglandin analog: a 3-month, open-label, replacement study in glaucoma patients.
    Nguyen QH; Earl M
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):541-4. PubMed ID: 20028261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.
    Ormrod D; McClellan K
    Drugs Aging; 2000 Dec; 17(6):477-96. PubMed ID: 11200308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices.
    Pajic B;
    Curr Med Res Opin; 2003; 19(2):95-101. PubMed ID: 12740152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed topical combinations in glaucomatous patients and ocular discomfort.
    Nebbioso M; Evangelista M; Librando A; Di Blasio D; Pescosolido N
    Expert Opin Pharmacother; 2012 Sep; 13(13):1829-35. PubMed ID: 22770575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. Additivity Study Group.
    Adamsons I; Clineschmidt C; Polis A; Taylor J; Shedden A; Laibovitz R
    J Glaucoma; 1998 Aug; 7(4):253-60. PubMed ID: 9713783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.